TITLE

Renal and systemic nitric oxide synthesis in rats with renal mass reduction

AUTHOR(S)
Aiello, Sistiana; Noris, Marina; Todeschini, Marta; Zappella, Sergio; Foglieni, Chiara; Benigni, Ariela; Corna, Daniela; Zoja, Carla; Cavallotti, Daniela; Remuzzi, Giuseppe
PUB. DATE
July 1997
SOURCE
Kidney International;Jul1997, Vol. 52 Issue 1, p171
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on renal and systemic nitric oxide synthesis in rats with renal mass reduction. Nitric-oxide (NO), an L-arginine derivative, is implicated in neuronal transmission, immune response and vasodilation, beside acting as a platelet function modulator. The conversion of L-arginine to L-citrulline that leads to the formation of NO is catalyzed by a family of NO synthase (NOS) enzymes that exists in at least three distict isoforms, neuronal NOS, inducible NOS and endothelial NOS.
ACCESSION #
14198807

 

Related Articles

  • Nitric oxide insufficiency and atherothrombosis. Voetsch, Barbara; Jin, Richard; Loscalzo, Joseph // Histochemistry & Cell Biology;Oct2004, Vol. 122 Issue 4, p353 

    Nitric oxide (NO) is a structurally simple compound that participates in a wide range of biological reactions to maintain normal endothelial function and an antithrombotic intravascular milieu. Among its principal effects are the regulation of vascular tone, vascular smooth muscle cell...

  • Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure. Seljeflot, Ingebjorg // Heart;Jun2012, Vol. 98 Issue 11, p831 

    An introduction is presented in which the editor discusses various article within the issue on topics including endothelial dysfunction, endothelial nitric oxide (NO) production and availability of arginine.

  • Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients. Chrapko, Wendy; Jurasz, Paul; Radomski, Marek W.; Archer, Stephen L.; Newman, Stephen C.; Baker, Glen; Lara, Nathalie; Le Mellédo, Jean-Michel // Neuropsychopharmacology;Jun2006, Vol. 31 Issue 6, p1286 

    Although major depression (MD) and cardiovascular disease (CVD) have been conclusively linked in the literature, the mechanism associating MD and CVD is yet undetermined. The purpose of this paper is to further investigate a potential mechanism involving nitric oxide (NO) and to examine the...

  • Physiology and pathophysiology of nitric oxide. Ignarro, Louis J. // Kidney International;Jun1996 Supplement, Vol. 49, pS2 

    Nitric oxide (NO) was discovered to be a potent vasodilator, inhibitor of platelet aggregation, and active species of nitroglycerin before the discovery of endothelium- derived relaxing factor (EDRF) in 1980. Subsequent studies revealed that EDRF is NO, and is synthesized by mammalian cells from...

  • The Physiology of Nitric Oxide: Control and Consequences. Fleming, Ingrid; Busse, Rudi // Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy A;Sep2004, Vol. 3 Issue 3, p189 

    Since its recognition as an endothelium-derived relaxing factor, the control and consequences of nitric oxide (NO) production has been investigated intensely. NO is not simply a vasodilator or regulator of smooth muscle tone but is a potent anti-platelet agent, neuromodulator and regulator of...

  • The Many Antithrombotic Actions of Nitric Oxide. Tziros, Constantine; Freedman, Jane E. // Current Drug Targets;Oct2006, Vol. 7 Issue 10, p1243 

    Vessel occlusion within a coronary artery is the precipitating event in unstable coronary syndromes and is primarily due to rupture of atheromatous plaque and subsequent thrombus formation. In the nondiseased vessel, the intact endothelium releases the vasodilator and antithrombotic agent nitric...

  • Lopinavir-Ritonavir: Effects on Endothelial Cell Function in Healthy Subjects. Grubb, Jessica R.; Dejam, André; Voell, Jocelyn; Blackwelder, William C.; Sklar, Peter A.; Kovacs, Joseph A.; Cannon, Richard O.; Masur, Henry; Gladwin, Mark T. // Journal of Infectious Diseases;6/1/2006, Vol. 193 Issue 11, p1516 

    To differentiate between the effects that antiretroviral drugs have on the endothelium and the secondary effects that they have on immune function, viral load, and dyslipidemia, 6 non-human immunodeficiency virus-infected human subjects were treated with lopinavir-ritonavir for 1 month and, on...

  • Investigation of Endothelial Control of Bone Blood Flow: Development of a Rabbit Tibia Ex Vivo Perfusion Model. Tu, Yuan-Kun; Kato, Teiji; Bishop, Allen T. // Journal of Musculoskeletal Research;Jun2000, Vol. 4 Issue 2, p85 

    An ex vivo rabbit tibia perfusion model was developed to investigate the vascular reactivity and vascular endothelial function of bone tissue. The tibiae of 36 adult New Zealand rabbits were isolated and perfused through the cannulated nutrient artery at a constant flow rate in an organ chamber....

  • DIHYDROBIOPTERIN (BH2): KEY DETERMINANT IN INFLUENCING ARGININE MEDIATED ENDOTHELIAL TOLERANCE AND DYSFUNCTION. Mohan, Srinidi; Patel, Harsh; Bolinaga, Jorge; Soekamto, Nathania; Achu, Lum; Teklemariam, Kefali // American Journal of Biochemistry & Biotechnology;2012, Vol. 8 Issue 2, p54 

    The redox-sensitive tetrahydrobiopterin (BH4) is an essential cofactor that is required by endothelial Nitric Oxide Synthase (eNOS) for L-arginine (ARG) mediated Nitric Oxide (NO) generation. Oxidation of BH4 causes cofactor insufficiency and uncoupling of eNOS, resulting in product switching...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics